Author Archives: Chandra Ganegoda

BriaCell Therapeutics Announces Proceeds of US$12.88 Million from Warrant Exercises

Proceeds will be used to advance clinical and research and development pipeline and for general ...

BriaCell to Host Corporate and Clinical Update Conference Call Wednesday, June 16, 2021 at 4:30 p.m. ET

BERKELEY, Calif. and VANCOUVER, British Columbia, June 09, 2021 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: ...

BriaCell Therapeutics Corp. Announces Closing of US$27.2 Million Private Placement

BERKELEY, Calif. and VANCOUVER, British Columbia, June 07, 2021 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. ...

BriaCell Therapeutics Corp. Announces US$27.2 Million Private Placement

BERKELEY, Calif. and VANCOUVER, British Columbia, June 03, 2021 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. ...

BriaCell Reports 12.0 Months Overall Survival Benefit in Advanced Breast Cancer; 100% Resolution of ‘Eye-Bulging’ Tumor

12.0 months average overall survival benefit, including 13.4 months in patients with 2+ HLA matches ...

BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting

BERKELEY, Calif. and VANCOUVER, British Columbia, May 19, 2021 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. ...

BriaCell CEO Gives Corporate Overview, Plans for Future in Audio Interview with SmallCapVoice.com

AUSTIN, Texas, April 21, 2021 (GLOBE NEWSWIRE) — SmallCapVoice.com Inc. (“SCV”) announces the availability of ...

BriaCell Welcomes BioPharma Industry Experts to its Board of Directors

BERKELEY, Calif., and VANCOUVER, British Columbia, March 18, 2019 – BriaCell® Therapeutics Corp. (“BriaCell®” or ...

Initial Research Report (by RB Milestone Group) – BriaCell Therapeutics Corp. June 21, 2018

Initial Research Report (by RB Milestone Group) – BriaCell Therapeutics Corp. June 21, 2018 ...

BriaCell Therapeutics Successfully Advances Towards Initiation of BriaVax™ Phase I/IIa Clinical Trial

October 8, 2015 Positive Release Testing Data From First Lot of Vaccine Submitted to FDA; ...